Registration Report Part B Section 4 · prune and tomato past, respectively. Concerning the...
Transcript of Registration Report Part B Section 4 · prune and tomato past, respectively. Concerning the...
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 1 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Art. 51
Extension of authorisation for minor uses
REGISTRATION REPORT
Part B
Section 4: Metabolism and Residues
Detailed summary of the risk assessment
Product code: 102000016538
Active Substance: Spirotetramat SC 100 (100
g/L)
Member State: The Netherlands
NATIONAL ASSESSMENT
Applicant: Bayer CropScience
Date: January 2019
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 2 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Table of Contents
IIIA 8 METABOLISM AND RESIDUES DATA ...................................................................... 4
IIIA 8.1 Stability of Residues .......................................................................................................... 5
IIIA 8.2 Supplementary studies on metabolism in plants or livestock ........................................ 5
IIIA 8.3 Supplementary residue trials (supervised field trials) ................................................... 6
IIIA 8.3.1 Other leafy vegetables excluding witloof chicory (watercress, lamb’s lettuce,
rocket, sea lavender) ......................................................................................................... 6
IIIA 8.3.2 Endive ............................................................................................................................... 12
IIIA 8.3.3 Baby leaf crops ................................................................................................................ 12
IIIA 8.3.4 Leafy brassica .................................................................................................................. 12
IIIA 8.3.5 Aromatic herbs ................................................................................................................ 18
IIIA 8.4 Supplementary Livestock Feeding Studies ................................................................... 18
IIIA 8.5 Supplementary Studies on Industrial Processing and/or Household
Preparation ...................................................................................................................... 18
IIIA 8.6 Supplementary Studies for Residues in Representative Succeeding Crops ............... 18
IIIA 8.7 Proposed Residue Definition and Maximum Residue Levels ...................................... 19
IIIA 8.7.1 Proposed residue definition ............................................................................................ 19
IIIA 8.7.2 Proposed maximum residue levels (MRLs) .................................................................. 19
IIIA 8.8.1 Pre-harvest interval (in days) for each relevant crop .................................................. 20
IIIA 8.8.2 Re-entry period (in days) for livestock, to areas to be grazed ..................................... 20
IIIA 8.8.3 Re-entry period for man to crops, buildings or spaces treated ................................... 20
IIIA 8.8.4 Withholding period (in days) for animal feedingstuffs ................................................ 20
IIIA 8.8.5 Waiting period before sowing or planting crop to be protected ................................. 20
IIIA 8.8.6 Waiting period between application and handling treated products ......................... 20
IIIA 8.8.7 Waiting period (in days) before sowing or planting succeeding crops ....................... 20
IIIA 8.9 Other/Special Studies ...................................................................................................... 20
IIIA 8.10 Estimation of Exposure Through Diet and Other Means ............................................ 21
IIIA 8.11 Summary and Evaluation of Residue Behaviour ......................................................... 22
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 3 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Appendix 1: List of data submitted in support of the extension of use ............................................ 24
Appendix 2: Critical Uses – justification and GAP tables ................................................................. 26
Appendix 3: Pesticide Residue Intake Model (PRIMO) .................................................................... 26
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 4 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8 METABOLISM AND RESIDUES DATA
Regulatory Background
The plant protection product Batavia (15615 N) is authorised in the Netherlands for indoor use on various
edible and non-edible commodities. With the current application, the applicant seeks for registration of
minor indoor uses in: other leafy vegetables excluding witloof chicory (watercress, lamb’s lettuce, rocket,
sea lavender), endive, vegetables sprouts, baby leaf crops, leafy brassica, aromatic herbs, and plant
breeding crops and basic seed production. Since the intended indoor use in plant breeding crops and basic
seed production is not relevant for the section of residues and consumer safety, this intended use will not
be discussed in this document.
It is noted that for the current application for extension of authorisation for minor uses, the risk envelop
approach is applied. Therefore, data points that are covered by the main authorisation will not be
summarised again.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 5 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.1 Stability of Residues
The stability of residues is covered by the main authorisation.
Conclusion:
Residues of spirotetramat should be considered stable for at least 18 months in high-water, high starch
and high oil content matrices when analysed for the sum of spirotetramat and spirotetramat-enol.
Spirotetramat-ketohydroxy, spirotetramat-enol-Glc and spirotetramat-mono hydroxy stable for at least 18
months in high-water, high starch and high oil content matrices, and 5 and 12 months in orange juice,
prune and tomato past, respectively.
Concerning the stability of residues in sample extracts, the analytical procedure is routinely monitored by
performing concurrent recoveries with each sample set when conducting residue analysis on regular
samples.
Table 8.1.1- 1 Summary of storage stability of total spirotetramat residues
Compound Plant matrix Stability (max. period tested)
(days) Storage conditions
Spirotetramat, BYI08330-enol,
BYI08330-ketohydroxy,
BYI08330 monohydroxy,
BYI08330 enol-glucoside,
Total residue of spirotetramat
Tomato Fruit
Potato Tuber
Head lettuce
Climbing French bean
Almond nutmeat
Tomato Paste
718 ≤ -18°C
Orange juice
Prunes 147 ≤ -18°C
IIIA 8.2 Supplementary studies on metabolism in plants or livestock
The metabolism in plants and livestock is covered by the main authorisation.
It is noted that during the peer review , the residue definitions in plants were proposed as "sum of
spirotetramat and spirotetramat-enol, expressed as spirotetramat" and "sum of spirotetramat,
spirotetramat-enol, spirotetramat-enol-Glc, spirotetramat-ketohydroxy and spirotetramat-monohydroxy,
expressed as spirotetramat" for monitoring and risk assessment, respectively (EFSA, 2013). However, the
current residue definition for monitoring as set in Reg. (EC) No 396/2005 is "sum of spirotetramat,
spirotetramat-enol, spirotetramat-enol-Glc, spirotetramat-ketohydroxy and spirotetramat-monohydroxy,
expressed as spirotetramat". Therefore, the latter residue definition including the parent and four
metabolites is considered for monitoring and risk assessment in this document.
Likewise, the residue definitions for livestock differ between the peer review and Reg. (EC) No
396/2005. In the peer review, the residue definitions were set as "spirotetramat-enol expressed as
spirotetramat" and "sum of spirotetramat-enol and spirotetramat-enol-GA expressed as spirotetramat" for
monitoring and riskassessment, respectively. In Reg. (EC) No 396/2005, the residue definitions are
"spirotetramat, spirotetramat-enol and spirotetramat-enolglucuronide, expressed as spirotetramat" for
monitoring and risk assessment alike. Similarily to plants, the residue definitions according to Reg. (EC)
No 396/2005 are considered in the current document.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 6 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.3 Supplementary residue trials (supervised field trials)
The critical uses applied for are summarised in Table 8.3-1.
Table 8.3-1: Summary of the critical GAPs for the proposed indoor uses of Batavia
Crop
Application Application rate per treatment
Method,
kind Number
Interval
(days) g as/hL
water
L/ha max. g as/ha
PHI
(days)
Other leafy vegetables
excluding witloof
chicory (watercress,
lamb’s lettuce, rocket,
sea lavender)
Spraying 2 14 7.5-37.5 200-1000 75 7
Endive Spraying 2 14 7.5-37.5 200-1000 75 7
Baby leaf crops Spraying 2 14 7.5-37.5 200-1000 75 7
Leafy brassica Spraying 2 14 7.5-37.5 200-1000 75 3
Aromatic herbs Spraying 2 14 7.5-37.5 200-1000 75 7
IIIA 8.3.1 Other leafy vegetables excluding witloof chicory (watercress, lamb’s lettuce,
rocket, sea lavender)
Table 8.3.1-1: Summary of the cGAP for the proposed indoor use of Batavia in other leafy vegetables
excluding witloof chicory (watercress, lamb’s lettuce, rocket, sea lavender)
Crop Country No. of
appli-
cations
Interval
(days)
Water rate
(L/ha)
Application
rate
(g a.s./ha)
PHI
(days)
Other leafy vegetables excluding
witloof chicory (watercress, lamb’s
lettuce, rocket, sea lavender)
NL 2 14 200-1000 75 7
Three studies investigating the magnitude of spirotetramat residues in lettuce are available that were
conducted in the growing seasons 2004 and 2005 under greenhouse conditions. The studies were already
evaluated in the DAR by Austria and by EFSA during the peer review of spirotetramat to support the
representative indoor use in lettuce according to the GAP 2 x 72 g/ha, interval 14 d, PHI 7 d (Austria,
2013; EFSA, 2013). The studies were considered acceptable and are therefore not summarised in detail
anymore in this document. Instead, only the summary tables of the supervised residue trials are presented
below for the sake of completeness. Residue levels were selected according to the residue definitions that
are currently in force (see IIIA 8.2). The slight difference in the application rate between the peer review
and the current application (72 g/ha cf. 75 g/ha) is considered to have a negligible impact on the residue
levels.
All trials were conducted in lettuce. According to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on
open leaf varieties of lettuce can be extrapolated to watercresses, lamb’s lettuce, rocket, and sea
lavanders. It is noted that the latter crop falls under purslanes in Annex I of Reg. (EC) No 396/2005 and
therefore, the MRL of purslanes applied to sea lavender. The crops under consideration are all minor
crops in NEU; therefore, 4 trials are considered sufficient for evaluation. From the available trials, 10
trials were conducted on open leaf varieties and are considered for evaluation. Based upon these trials, an
MRL of 6.00 mg/kg is calculated. Existing MRLs of spirotetramat as established by Reg. (EU) No
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 7 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
2017/1016 in watercresses, lamb’s lettuce, rocket, and purslanes/sea lavanders are at 7.00 mg/kg; an MRL
exceendance is not expected.
Table 8.3.1-2: Summary of spirotetramat residues to support the use in other leafy vegetables excluding witloof
chicory (watercress, lamb’s lettuce, rocket, sea lavender)
Crop Region Individual trial results (mg/kg)
Mo: according to residue definition for
monitoring
RA: according to residue definition for risk
assessment
MRL
proposal
(mg/kg)
STMR
(mg/kg)
HR
(mg/kg)
Median
CF
Other leafy
vegetables
excluding
witloof chicory
(watercress,
lamb’s lettuce,
rocket, sea
lavender)
2 x 75 g/ha,
interval 14 d,
PHI 7 d
EU
indoor
Trials conducted in lettuce (open leaf varieties)
Mo/RA: 0.374, 0.387, 1.057, 1.296, 1.445, 1.642,
1.774, 1.958, 2.327, 3.442
6.00 1.54 3.44 -
Reference: Determination of Residues of BYI08330 in/on Lettuce after Spraying of BYI08330 (150 OD) in the
Greenhouse in Greece, France, Netherlands, Portugal Germany and Spain Report/Doc. number: RA-2170/05, including trials no. R 2005 1023/3, R 2005 1024/1, R 2005 1026/8, R 2005 1027/6, R
2005 1028/4, R 2005 1029/2, R 2005 1030/6, R 2005 1031/4
Guideline(s): EU Council Directive 91/414/EEC Annex II, part A section 6 and Annex III, part A, section 8
residues in or on treated products, food and feed
GLP: yes
Deviations: no
Validity: yes
Reference: Determination of Residues of BYI08330 in/on Lettuce after Spraying of BYI08330 (100 OD) in the
Greenhouse in Germany, Southern France, Italy and Spain
Report/Doc. number: RA-2054/04, including trials no. R 2004 0393/3, R 2004 0394/1, R 2004 0396/8, R 20040397/6, R
2004 0398/4, R 2004 0399/2, R 2004 0401/8, R 2004 0402/6
Guideline(s): EU Council Directive 91/414/EEC Annex II, part A section 6 and Annex III, part A, section 8
residues in or on treated products, food and feed
GLP: yes
Deviations: no
Validity: yes
Reference: Determination of Residues of BYI08330 in/on Lettuce after Spraying of BYI08330 (240 SC) in the
Greenhouse in Germany, Italy and Spain
Report/Doc. number: RA-2113/04, including trials no. R 2004 0685/1, R 2004 0687/8, R 2004 0688/6, R 2004 0689/4
Guideline(s): EU Council Directive 91/414/EEC Annex II, part A section 6 and Annex III, part A, section 8
residues in or on treated products, food and feed
GLP: yes
Deviations: no
Validity: yes
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 8 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Report No.
Trial No
Location
Commodit
y/
Variety
Date of
1. Sowing or
planting
2. Flowering
3. Harvest
Application rate
per treatment Dates of
treatment(s)
or no. of
treatment
and last date
Growth
stage at
last
treatment
or date
Portion
analysed
Residues, expressed as spirotetramat (BYI 08330)
[mg/kg]
PHI
[days] Remarks
kg a.s./
ha
water
l/ha
kg
a.s./hl
BYI
08330
BYI
08330-
enol
BYI
08330
ketohy
droxy
BYI
08330
monoh
ydroxy
BYI
08330
enol-Glc
Total
Greenhouse trials
RA-2054/04
R 2004 0393/3
D-40764
Langenfeld,
Germany
Lettuce /
Alexandria
(Butter-
head
variety)
1.
22.04.2004
3.
15.06.2004
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
18.05.2004
25.04.2004
01.06.2004
BBCH 47 head
head
head
head
head
head
0.04
0.35
0.38
0.28
0.02
0.01
0.096
0.35
0.27
0.25
0.091
0.053
0.031
0.076
0.043
0.061
0.039
0.013
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.030
0.037
0.037
0.052
0.060
0.081
0.209
0.825
0.742
0.655
0.222
0.169
0*
0
1
3
7
13
formulatio
n: 100 OD;
Closed leaf
variety
RA-2054/04
R 2004 0394/1
F-31790 St.
Jory, Southern
France
Lettuce /
Alexandria
(Butter-
head
variety)
1.
24.03.2004
3.
15.05.2004
0.072
0.072
0.072
1000
1000
1000
0.007
0.007
0.007
29.04.2004
05.05.2004
12.05.2004
BBCH 48 head
head
head
head
head
head
0.07
0.49
0.63
0.06
0.02
0.01
0.12
0.69
0.32
0.18
0.080
0.031
0.041
0.16
0.090
0.047
0.025
0.012
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.022
0.042
0.027
0.038
0.059
0.067
0.265
1.394
1.079
0.337
0.196
0.132
0*
0
1
3
7
14
formulatio
n: 100 OD;
Closed leaf
variety
RA-2054/04
R 2004 0396/8
D-42799
Leichlingen,
Germany
Lettuce /
Roderik
(Butter-
head
variety)
1.
02.02.2004
3.
15.04.2004
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
30.03.2004
06.04.2004
13.04.2004
BBCH 47 head
head
head
head
2.2
1.7
1.5
1.9
0.66
0.50
0.54
0.59
0.079
0.059
0.070
0.079
<0.012
<0.012
<0.012
<0.012
0.014
0.012
0.017
0.032
2.965
2.283
2.139
2.613
0
1
3
6
formulatio
n: 100 OD;
Closed leaf
variety
RA-2054/04
R 2004 0397/6
I-00050
Palidoro
Fiumicino, Italy
Lettuce /
Kereon
(Butter-
head
variety)
1.
11.03.2004
3.
26.04.2004
0.072
0.072
0.072
500
500
500
0.014
0.014
0.014
09.04.2004
16.04.2004
23.04.2004
BBCH 48 head
head
head
head
1.9
1.7
1.3
1.2
0.35
0.37
0.28
0.21
0.070
0.072
0.046
0.032
<0.012
<0.012
<0.012
<0.012
0.037
0.042
0.043
0.048
2.369
2.196
1.681
1.502
0
1
3
7
formulatio
n: 100 OD;
Closed leaf
variety
RA-2054/04
R 2004 0398/4
I-70043
Monopoli, Italy
Lettuce /
Lollo rosso
(Loose-
Leaf
variety)
1.
11.10.2004
3. 05.01-
18.01.2005
0.072
0.072
0.072
800
800
800
0.009
0.009
0.009
22.12.2004
29.12.2004
05.01.2005
BBCH 43 head
head
head
head
head
head
1.7
5.9
5.1
3.7
2.6
0.60
0.49
0.73
0.68
0.76
0.53
0.24
0.13
0.14
0.14
0.17
0.15
0.079
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.051
0.056
0.052
0.13
0.15
0.093
2.383
6.838
5.984
4.772
3.442
1.024
0*
0
1
3
6
14
formulatio
n: 100 OD;
Open leaf
variety
RA-2054/04
R 2004 0399/2
E-08410
Bigues, Spain
Lettuce /
Batavia
(Loose-
Leaf
variety)
1.
20.01.2004
3.
15.03.2004
0.0720
0.0774
0.0720
800
860
1000
0.009
0.009
0.007
23.02.2004
01.03.2004
08.03.2004
BBCH 46
– 49
head
head
head
head
head
head
0.54
1.4
1.2
0.73
0.52
0.39
0.52
0.75
0.71
0.60
0.51
0.22
0.18
0.24
0.22
0.22
0.17
0.081
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.057
0.058
0.071
0.067
0.084
0.074
1.309
2.46
2.213
1.629
1.296
0.777
0*
0
1
3
7
14
formulatio
n: 100 OD;
Open leaf
variety
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 9 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Report No.
Trial No
Location
Commodit
y/
Variety
Date of
1. Sowing or
planting
2. Flowering
3. Harvest
Application rate
per treatment Dates of
treatment(s)
or no. of
treatment
and last date
Growth
stage at
last
treatment
or date
Portion
analysed
Residues, expressed as spirotetramat (BYI 08330)
[mg/kg]
PHI
[days] Remarks
kg a.s./
ha
water
l/ha
kg
a.s./hl
BYI
08330
BYI
08330-
enol
BYI
08330
ketohy
droxy
BYI
08330
monoh
ydroxy
BYI
08330
enol-Glc
Total
RA-2054/04
R 2004 0401/8
I-70043
Monopoli, Italy
Lettuce /
Versai RZ
(Loose-
Leaf
variety)
1.
28.12.2003
3.
15.03.2004
0.072
0.072
0.072
800
800
800
0.009
0.009
0.009
27.02.2004
05.03.2004
12.03.2004
BBCH 49 head
head
head
head
2.2
1.1
1.4
1.0
0.55
0.35
0.31
0.27
0.18
0.11
0.093
0.096
<0.012
<0.012
<0.012
<0.012
0.056
0.037
0.049
0.067
2.998
1.609
1.864
1.445
0
1
3
7
formulatio
n: 100 OD;
Open leaf
variety
RA-2054/04
R 2004 0402/6
E-41310
Brenes, Spain
Lettuce /
Solsun
(Nun 8801
LT)
(Loose-
Leaf
variety)
1.
19.10.2004
3.
01.12.2004 –
28.02.2005
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
27.12.2004
03.01.2005
10.01.2005
BBCH 47 head
head
head
head
2.8
1.9
2.6
1.7
0.25
0.20
0.31
0.20
0.041
0.035
0.052
0.038
<0.012
<0.012
<0.012
<0.012
<0.008
<0.008
<0.008
0.008
3.111
2.155
2.982
1.958
0
1
3
7
formulatio
n: 100 OD;
Open leaf
variety
RA-2170/05
R 2005 1023/3
GR-19007 Kato
Souli, Greece
Lettuce /
Manita
1. 11.09.-
10.10.2005
3. 21.-
22.12.2005
0.072
0.072
500
500
0.014
0.014
24.11.2005
08.12.2005
BBCH 45 head
head
head
head
head
head
0.10
1.5
1.6
1.4
0.70
0.58
0.12
0.31
0.37
0.40
0.26
0.28
0.026
0.039
0.057
0.063
0.053
0.053
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.027
0.025
0.033
0.034
0.032
0.046
0.285
1.886
2.072
1.909
1.057
0.971
0*
0
1
3
7
14
formulatio
n: 150 OD;
Open leaf
variety
RA-2170/05
R 2005 1024/1
F-86380
Quyilly, France
Lettuce /
Bastille
1.
15.09.2005
3. 29.10.-
10.11.2005
0.072
0.072
800
800
0.009
0.009
10.10.2005
24.10.2005
BBCH 48 head
head
head
head
head
head
0.11
2.0
2.1
1.6
0.19
0.09
0.038
0.57
0.16
0.18
0.078
0.023
0.063
0.11
0.15
0.17
0.084
0.052
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.015
0.022
0.017
0.018
0.023
0.013
0.238
2.714
2.439
1.98
0.387
0.19
0*
0
1
3
7
14
formulatio
n: 150 OD;
Open leaf
variety
RA-2170/05
R 2005 1026/8
NL-1852 RH
Heiloo,
Netherlands
Lettuce /
Varinka
1. 14.09.-
05.10.2005
3. 12.-
15.12.2005
0.072
0.072
1000
1000
0.007
0.007
22.11.2005
06.12.2005
BBCH 48 head
head
head
head
head
head
0.45
1.6
1.5
1.4
1.3
0.87
0.18
0.34
0.30
0.29
0.35
0.26
0.063
0.067
0.085
0.082
0.086
0.066
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
<0.008
<0.008
<0.008
<0.008
<0.008
<0.008
0.713
2.027
1.905
1.792
1.756
1.216
0*
0
1
3
7
14
formulatio
n: 150
OD;
Closed leaf
variety
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 10 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Report No.
Trial No
Location
Commodit
y/
Variety
Date of
1. Sowing or
planting
2. Flowering
3. Harvest
Application rate
per treatment Dates of
treatment(s)
or no. of
treatment
and last date
Growth
stage at
last
treatment
or date
Portion
analysed
Residues, expressed as spirotetramat (BYI 08330)
[mg/kg]
PHI
[days] Remarks
kg a.s./
ha
water
l/ha
kg
a.s./hl
BYI
08330
BYI
08330-
enol
BYI
08330
ketohy
droxy
BYI
08330
monoh
ydroxy
BYI
08330
enol-Glc
Total
RA-2170/05
R 2005 1027/6
P-2560 Torres
Vedras,
Portugal
Lettuce /
Tradition
1.
18.08.2005
3. 26.-
27.09.2005
0.072
0.072
500
500
0.014
0.014
26.08.2005
09.09.2005
BBCH 41 head
head
head
head
head
head
<0.01
1.4
1.6
1.4
0.17
0.02
<0.012
1.0
0.38
0.33
0.12
0.043
<0.012
0.067
0.11
0.099
0.034
0.012
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
<0.008
0.015
0.020
0.045
0.038
0.024
0.054
2.494
2.122
1.886
0.374
0.111
0*
0
1
3
7
14
formulatio
n: 150 OD;
Open leaf
variety
RA-2170/05
R 2005 1028/4
F-31790 St.
Jory, France
Lettuce /
Cabanon
1.
20.09.2005
3. 05.-
15.01.2006
0.072
0.072
800
800
0.009
0.009
19.12.2005
03.01.2006
BBCH 45 head
head
1.8
1.5
0.22
0.23
0.047
0.081
<0.012
<0.012
0.008
0.012
2.087
1.835
0
7
formulatio
n: 150 OD;
Closed leaf
variety
RA-2170/05
R 2005 1029/2
F-84140
Montfavet,
France
Lettuce /
Arcadia
1. 20.09.-
05.10.2005
3. 28.-
29.11.2005
0.072
0.072
1000
1000
0.007
0.007
07.11.2005
21.11.2005
BBCH 48 head
head
1.5
0.85
0.66
0.41
0.11
0.12
<0.012
<0.012
0.015
0.014
2.297
1.406
0
7
formulatio
n: 150 OD;
Closed leaf
variety
RA-2170/05
R 2005 1030/6
D-40764
Langenfeld,
Germany
Lettuce /
Alexandria
1.
26.07.2005
3. 30.08.-
10.09.2005
0.072
0.072
600
600
0.012
0.012
10.08.2005
24.08.2005
BBCH 43 head
head
1.3
0.05
0.30
0.056
0.014
0.031
<0.012
<0.012
0.008
0.014
1.634
0.163
0
7
formulatio
n: 150 OD;
Closed leaf
variety
RA-2170/05
R 2005 1031/4
E-08410 Bigues
i Riells, Spain
Lettuce /
Batavia
1.
26.09.2005
3.
28.12.2005 –
05.01.2006
0.0764
0.0720
636
900
0.008
0.012
07.12.2005
20.12.2005
BBCH 48 head
head
1.8
1.6
0.57
0.58
0.12
0.12
<0.012
<0.012
0.008
0.015
2.51
2.327
0
7
formulatio
n: 150 OD;
Open leaf
variety
RA-2113/04
R 2004 0685/1
D-40764
Langenfeld,
Germany
Lettuce /
Alexandria
1.
22.04.2004
3.
15.06.2004
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
18.05.2004
25.05.2004
01.06.2004
BBCH 47 head
head
head
head
head
head
0.02
0.42
0.5
0.31
0.03
0.01
0.088
0.38
0.29
0.21
0.1
0.054
0.023
0.093
0.048
0.037
0.028
0.012
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.036
0.042
0.051
0.056
0.07
0.084
0.179
0.947
0.901
0.625
0.24
0.172
0*
0
1
3
7
13
formulatio
n: 240 SC;
addition of
0.2% RME
500;
Closed leaf
variety
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 11 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Report No.
Trial No
Location
Commodit
y/
Variety
Date of
1. Sowing or
planting
2. Flowering
3. Harvest
Application rate
per treatment Dates of
treatment(s)
or no. of
treatment
and last date
Growth
stage at
last
treatment
or date
Portion
analysed
Residues, expressed as spirotetramat (BYI 08330)
[mg/kg]
PHI
[days] Remarks
kg a.s./
ha
water
l/ha
kg
a.s./hl
BYI
08330
BYI
08330-
enol
BYI
08330
ketohy
droxy
BYI
08330
monoh
ydroxy
BYI
08330
enol-Glc
Total
RA-2113/04
R 2004 0687/8
I-70043
Monopoli, Italy
Lettuce /
Lollo rosso
1.
11.10.2004
3. 05.01. –
18.01.2005
0.072
0.072
0.072
800
800
800
0.009
0.009
0.009
22.12.2004
29.12.2004
05.01.2005
BBCH 43 head
head
head
head
head
head
1.2
4.2
3.2
1.7
0.99
0.21
0.36
0.66
0.49
0.62
0.41
0.23
0.12
0.15
0.12
0.14
0.11
0.069
<0.012
<0.012
<0.012
<0.012
<0.012
<0.012
0.042
0.043
0.042
0.11
0.12
0.11
1.734
5.065
3.864
2.582
1.642
0.631
0*
0
1
3
7
14
formulatio
n: 240 SC;
addition of
0.2% RME
500;
Open leaf
variety
RA-2113/04
R 2004 0688/6
E-41340
Brenes, Spain
Lettuce /
Solsun
(Nun 8801
LT)
1.
19.10.2004
3.
01.12.2005 –
28.02.2005
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
27.12.2004
03.01.2005
10.01.2005
BBCH 47 head
head
head
head
head
1.1
1.8
2.2
1.7
1.5
0.15
0.21
0.29
0.18
0.21
0.036
0.032
0.05
0.044
0.044
<0.012
<0.012
<0.012
<0.012
<0.012
<0.008
<0.008
<0.008
<0.008
<0.008
1.306
2.062
2.56
1.944
1.774
0*
0
1
3
7
formulatio
n: 240 SC;
addition of
0.2% RME
500;
Open leaf
variety
RA-2113/04
R 2004 0689/4
D-42799
Leichlingen,
Germany
Lettuce /
Roderick
1.
02.02.2004
3.
15.04.2004
0.072
0.072
0.072
600
600
600
0.012
0.012
0.012
30.03.2004
06.04.2004
13.04.2004
BBCH 47 head
head
head
head
head
1.2
2.1
1.8
1.6
1.5
0.19
0.28
0.25
0.27
0.21
0.064
0.081
0.089
0.08
0.066
<0.012
<0.012
<0.012
<0.012
<0.012
0.01
0.012
0.01
0.13
0.019
1.476
2.485
2.161
2.092
1.807
0*
0
1
3
6
formulatio
n: 240 SC;
addition of
0.2% RME
500;
Closed leaf
variety
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 12 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.3.2 Endive
Table 8.3.2-1: Summary of the cGAP for the proposed indoor use of Batavia in endive
Crop Country No. of
appli-
cations
Interval
(days)
Water rate
(L/ha)
Application
rate
(g a.s./ha)
PHI
(days)
Endive NL 2 14 200-1000 75 7
According to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on open leaf varieties of lettuce can be
extrapolated to endives. Endive is considered as a minor crop in NEU; therefore, 4 trials are considered
sufficient for evaluation. The 10 trials that were conducted on open leaf varieties of lettuce (see IIIA
8.3.1) are considered acceptable for evaluation. Based upon these trials, an MRL of 6.00 mg/kg is
calculated. The existing MRL of spirotetramat as established by Reg. (EU) No 2017/1016 in endive is at
7.00 mg/kg; an MRL exceendance is not expected.
IIIA 8.3.3 Baby leaf crops
Table 8.3.3-1: Summary of the cGAP for the proposed indoor use of Batavia in baby leaf crops
Crop Country No. of
appli-
cations
Interval
(days)
Water rate
(L/ha)
Application
rate
(g a.s./ha)
PHI
(days)
Baby leaf crops NL 2 14 200-1000 75 7
According to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on open leaf varieties of lettuce can be
extrapolated to baby leaf crops. Baby leaf crops are considered as a minor crop in NEU; therefore, 4 trials
are considered sufficient for evaluation. The 10 trials that were conducted on open leaf varieties of lettuce
(see IIIA 8.3.1) are considered acceptable for evaluation. Based upon these trials, an MRL of 6.00 mg/kg
is calculated. The existing MRL of spirotetramat as established by Reg. (EU) No 2017/1016 in baby leaf
crops is at 7.00 mg/kg; an MRL exceendance is not expected.
IIIA 8.3.4 Leafy brassica
Table 8.3.4-1: Summary of the cGAP for the proposed indoor use of Batavia in leafy brassica
Crop Country No. of
appli-
cations
Interval
(days)
Water rate
(L/ha)
Application
rate
(g a.s./ha)
PHI
(days)
Leafy brassica NL 2 14 200-1000 75 3
To support the indoor use in leafy brassica, two new studies in paksoi were submitted. These studies are
summarised below. The study summary table for both studies is shown in Table 8.3.4-4 and an overview
of residue levels and the derived endpoints are shown in Table 8.3.4-2.
Four indoor trials were conducted in paksoi to support the intended use in leafy brassica. Leafy brassica
are a minor crop in NEU, therefore 4 trials are required to support the intended use. Paksoi falls under
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 13 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Chinese cabbages/pe-tsai in Annex I of Reg. (EC) No 396/2005. According to SANCO/7525/VI/95 Rev.
9 (March 2011), trials on Chinese cabbages cannot be used to support the intended use in the whole
subgroup of leafy brassica. Therefore, no trials are available for evaluation of the intended use in the
whole subgroup of leafy brassica.
In agreement with the applicant, the intended use in leafy brassica was restricted to Chinese cabbage only.
Based upon the available trials in paksoi, an MRL of 4.00 mg/kg is calculated. The existing MRL of
spirotetramat as established by Reg. (EU) No 2017/1016 in Chinese cabbage is at 7.00 mg/kg; an MRL
exceendance is not expected.
Table 8.3.4-2: Summary of spirotetramat residues to support the use in leafy brassica
Crop Region Individual trial results (mg/kg)
Mo: according to residue definition for
monitoring
RA: according to residue definition for risk
assessment
MRL
proposal
(mg/kg)
STMR
(mg/kg)
HR
(mg/kg)
Median
CF
Leafy brassica
Chinese
cabbage
2 x 75 g/ha,
interval 14 d,
PHI 3 d
EU
indoor
Trials conducted in paksoi cannot be used to support
the intended use in leafy brassica. In agreement with
the applicant, the intended use was amended to
Chinese cabbage only.
Mo/RA: 2x 0.80, 1.4, 1.9
4.00 1.1 1.9 -
Reference: Determnination of the decline of residues of spirotetramat and its metabolites
in protected Paksoi after 2 applications with Movento in The Netherlands,
2012
Report/Doc. number: R-12-35-NL-01
Guideline(s): Directive 91/414/EEC Annex II, part A section 6 and Annex III, part A, section 8;
Appendix B of SANCO/7029/VI/95 rev. 5; Directive 91/414/EEC Annex II, part
A section 4 and Annex III, part A, section 5
GLP: yes
Deviations: no
Validity: yes
Materials & methods
The objective of the study is to determine the decline of the residues of spirotetramat and its metabolites
in protected paksoi in two trials in the Netherlands resulting from two applications of Movento. Movento
is an SC formulation containing 100 g/L spirotetramat as active substance. The test item is considered
adequate to support the intended uses of Batavia in leafy brassica. Each trials consisted of an untreated
and a treated plot. Two foliar applications at nominally 75 g a.s./ha were conducted on the treated plots
with an interval of 14 days. Both applications were performed between growth stages BBCH 44-47.
Specimens from treated plots were taken at -0 (sampling prior to last application), 0, 1, 3, and 7 days after
the last application for both trials. Specimens of control samples were taken at -0 and 3 days after the last
application. Specimens were frozen within 12 hours after sampling and kept below -18 °C during storage.
Paksoi specimens were analysed for spirotetramat and its metabolites spirotetramat-enol, spirotetramat-
ketohydroxy, spirotetramat-monohydroxy, and spirotetramat-enol-glucoside using the validated Bayer
Crop Science (BCS) LC-MS/MS method 01207. The LOQ of the method is 0.01 mg/kg for each analyte.
During the analysis of field samples, concurrent recoveries were determined.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 14 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Results and discussion
The trials were conducted according to the intended GAP for leafy brassica (2 x 75 g a.s./ha, interval 14
d, PHI 3 d).
Samples were stored for maximally 3 months. This period is sufficiently covered by available storage
stability data.
The concurrent recoveries are shown in Table 8.3.4-3. Individual and overall recoveries, as well as the
RSD, were within the acceptable ranges. The analytical method is considered acceptable.
Table 8.3.4-3: Concurrent recoveries measured during the analysis of field samples.
Analyte Fortification level Single recoveries [%] Overall ± RSD [%]
Spirotetramat 0.01 99, 107 95 ± 9.0
0.10 103, 95
0.50 89
0.75 80
2.0 90, 95
Spirotetramat-enol 0.01 88, 92 90 ± 12
0.10 93, 91
0.50 77
0.75 73
2.0 102, 104
Spirotetramat-ketohydroxy 0.01 106, 89 94 ± 12
0.10 110, 95
0.50 83
0.75 83
Spirotetramat-monohydroxy 0.01 102, 96 92 ± 13
0.10 104, 97
0.50 78
0.75 77
Spirotetramat-enol-gulucoside 0.01 97, 90 87 ± 13
0.10 101, 86
0.50 75
0.75 72
No residues were measured in any control sample. Residue levels in paksoi resulting from the treatment
with Movento are shown in Table 8.3.4-5.
Reference: Determnination of the magnitude of the residues of spirotetramat and its
metabolites in protected Paksoi after 2 applications with Movento in The
Netherlands, 2012
Report/Doc. number: R-12-35-NL-02
Guideline(s): Directive 91/414/EEC Annex II, part A section 6 and Annex III, part A, section 8;
Appendix B of SANCO/7029/VI/95 rev. 5; Directive 91/414/EEC Annex II, part
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 15 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
A section 4 and Annex III, part A, section 5
GLP: yes
Deviations: no
Validity: yes
Materials & methods
The objective of the study is to determine the decline of the residues of spirotetramat and its metabolites
in protected paksoi in two trials in the Netherlands resulting from two applications of Movento. Movento
is an SC formulation containing 100 g/L spirotetramat as active substance. The test item is considered
adequate to support the intended uses of Batavia in leafy brassica. Each trials consisted of an untreated
and a treated plot. Two foliar applications at nominally 75 g a.s./ha were conducted on the treated plots
with an interval of 14 days. Both applications were performed between growth stages BBCH 46-49.
Specimens from treated and untreated plots were taken 3 days after the last application for both trials.
Specimens were frozen within 12 hours after sampling and kept below -18 °C during storage.
Paksoi specimens were analysed for spirotetramat and its metabolites spirotetramat-enol, spirotetramat-
ketohydroxy, spirotetramat-monohydroxy, and spirotetramat-enol-glucoside using the validated Bayer
Crop Science (BCS) LC-MS/MS method 01207. The LOQ of the method is 0.01 mg/kg for each analyte.
During the analysis of field samples, concurrent recoveries were determined.
Results and discussion
The trials were conducted according to the intended GAP for leafy brassica (2 x 75 g a.s./ha, interval 14
d, PHI 3 d).
Samples were stored for maximally 2.5 months. This period is sufficiently covered by available storage
stability data.
The concurrent recoveries are shown in Table 8.3.4-4. Individual and overall recoveries, as well as the
available RSD values, were within the acceptable ranges. It is noted that for spirotetramat-ketohydroxy,
spirotetramat-monohydroxy, and spirotetramat-enol-glucoside, only two procedural recoveries were
determined and therefore, no RSD could be determnined. Although additional concurrent recoveries are
desirable, the analytical method is considered acceptable.
Table 8.3.4-4: Concurrent recoveries measured during the analysis of field samples.
Analyte Fortification level Single recoveries [%] Overall ± RSD [%]
Spirotetramat 0.01 101, 109 99 ± 8.1
0.10 91
0.50 94
Spirotetramat-enol 0.01 101, 101 97 ± 5.9
0.10 96
0.50 89
Spirotetramat-ketohydroxy 0.01 82 81
0.10 79
Spirotetramat-monohydroxy 0.01 93 92
0.10 91
Spirotetramat-enol-gulucoside 0.01 88 88
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 16 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
0.10 88
No residues were measured in any control sample. Residue levels in paksoi resulting from the treatment
with Movento are shown in Table 8.3.4-5.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 17 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Table 8.3.4-5: Overview of the available residue trials in paksoi following foliar treatment with spirotetramat
Report No.
Trial No
Location
Commodit
y/
Variety
Date of
1. Sowing or
planting
2. Flowering
3. Harvest
Application rate
per treatment Dates of
treatment(s)
or no. of
treatment
and last date
Growth
stage at
last
treatment
or date
Portion
analysed
Residues, expressed as spirotetramat (BYI 08330)
[mg/kg]
PHI
[days] Remarks
g a.s./
ha
water
l/ha
g
a.s./hl
BYI
08330
BYI
08330-
enol
BYI
08330
ketohy
droxy
BYI
08330
monoh
ydroxy
BYI
08330
enol-Glc
Total
Greenhouse trials
R12-35-NL-01,
R12-351-01,
2991 SE
Barendrecht,
NL
Paksoi, Joi
Choi
1. 22/02/12
2. –
3. –
75.40
74.89
498
495
-
-
12/03/12
26/03/12
44
46-47
Plant
without
roots
0.02
1.7
1.5
1.0
0.79
0.10
2.5
1.2
0.80
0.59
0.02
0.08
0.07
0.06
0.04
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
0.15
4.3
2.9
1.9
1.4
-0*
0
1
3
7
R12-35-NL-01,
R12-351-02,
2995 BJ
Heerjansdam,
NL
Paksoi, Joi
Choi
1. 21/02/12
2. –
3. –
73.89
75.60
488
500
-
-
12/03/12
26/03/12
44
47
Plant
without
roots
<0.01
0.88
0.81
0.59
0.36
0.01
1.6
1.1
0.73
0.52
<0.01
0.06
0.06
0.04
0.03
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
0.05
2.5
2.0
1.4
0.93
-0*
0
1
3
7
R12-35-NL-02,
R12-352-01,
3335 LG
Zwijndrecht,
NL
Paksoi, Joi
Choi
1. 04/09/12
2. –
3. –
76.6
76.6
507
507
-
-
14/09/12
28/09/12
46
48-49
Plant
without
roots
0.48 0.28 0.04 <0.01 <0.01 0.80 3
R12-35-NL-02,
R12-352-02,
Heerjansdam,
NL
Paksoi, Joi
Choi
1. 25/08/12
2. –
3. –
79.1
78.1
523
517
-
-
14/09/12
28/09/12
46
48-49
Plant
without
roots
0.48 0.29 0.03 <0.01 <0.01 0.80 3
* -0: sampling prior to last application
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 18 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.3.5 Aromatic herbs
Table 8.3.5-1: Summary of the cGAP for the proposed indoor use of Batavia in aromatic herbs
Crop Country No. of
appli-
cations
Interval
(days)
Water rate
(L/ha)
Application
rate
(g a.s./ha)
PHI
(days)
Aromatic herbs NL 2 14 200-1000 75 7
According to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on open leaf varieties of lettuce can be
extrapolated to the whole subgroup (f) of herbs and edible flower. Due to a discrepancy between Annex I
of Reg. (EC) No 396/2005 and the Dutch list of uses, the subgroup (f) of herbs and edible flowers as
listed in Annex I only includes the aromatic herbs as listed in the Dutch list of uses. Therefore, an
application was made for aromatic herbs according to the Dutch list of uses. Herbs and edible
flower/aromatic herbs are considered as minor crops in NEU; therefore, 4 trials are considered sufficient
for evaluation. The 10 trials that were conducted on open leaf varieties of lettuce (see IIIA 8.3.1) are
considered acceptable for evaluation. Based upon these trials, an MRL of 6.00 mg/kg is calculated. The
existing MRL of spirotetramat as established by Reg. (EU) No 2017/1016 in herbs and edible
flowers/aromatic herbs is at 4.00 mg/kg; an MRL exceedance cannot be excluded. At the time point of
MRL setting (EFSA, 2011), the same data set was available as the one presented in this dossier. In the
Reasoned Opinion, however, a mistake was apparently made since the highest residue from the
greenhouse trials in open leaf varieties (3.442 mg/kg) was not considered in the Reasoned Opinion. There
are no obvious reasons why this value should be discarded from the data set. Therefore, the value is
considered within this application. As a consequence, the existing MRL is expected to be exceeded.
However, considering that 7 out of the 10 available trials were conducted with three applications instead
of the intended two, residue levels are rather overestimated. This is highlighted by the fact that the three
available trials conducted with two applications resulted in lower residue levels (0.74-1.057 mg/kg cf.
1.296-3.442 mg/kg for two and three applications, respectively). Based upon expert judgement, it is not
expected that the existing MRL will be exceeded if aromatic herbs are treated according to the intended
GAP.
IIIA 8.4 Supplementary Livestock Feeding Studies
Residues in livestock are not covered by the main authorisation.
Of the crops under consideration only kale, which falls under the leafy brassica, may be fed to livestock.
Since no supervised residue trials are available to support this use, the dietary burden cannot be
calculated. Of the uses recommended for authorisation, no crops are fed to livestock and therefore the
aspect of residues in livestock does not need to be addressed.
IIIA 8.5 Supplementary Studies on Industrial Processing and/or Household
Preparation
The aspect of residues in processed commodities is covered by the main authorization.
IIIA 8.6 Supplementary Studies for Residues in Representative Succeeding Crops
The aspect of residues in succeeding crops is covered by the main authorisation.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 19 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.7 Proposed Residue Definition and Maximum Residue Levels
IIIA 8.7.1 Proposed residue definition
The proposed residue definitions are covered by the main authorisation.
It is noted that during the peer review , the residue definitions in plants were proposed as "sum of
spirotetramat and spirotetramat-enol, expressed as spirotetramat" and "sum of spirotetramat,
spirotetramat-enol, spirotetramat-enol-Glc, spirotetramat-ketohydroxy and spirotetramat-monohydroxy,
expressed as spirotetramat" for monitoring and risk assessment, respectively (EFSA, 2013). However, the
current residue definition for monitoring as set in Reg. (EC) No 396/2005 is "sum of spirotetramat,
spirotetramat-enol, spirotetramat-enol-Glc, spirotetramat-ketohydroxy and spirotetramat-monohydroxy,
expressed as spirotetramat". Therefore, the latter residue definition including the parent and four
metabolites is considered for monitoring and risk assessment in this document.
Likewise, the residue definitions for livestock differ between the peer review and Reg. (EC) No
396/2005. In the peer review, the residue definitions were set as "spirotetramat-enol expressed as
spirotetramat" and "sum of spirotetramat-enol and spirotetramat-enol-GA expressed as spirotetramat" for
monitoring and riskassessment, respectively. In Reg. (EC) No 396/2005, the residue definitions are
"spirotetramat, spirotetramat-enol and spirotetramat-enolglucuronide, expressed as spirotetramat" for
monitoring and risk assessment alike. Similarily to plants, the residue definitions according to Reg. (EC)
No 396/2005 are considered in the current document.
IIIA 8.7.2 Proposed maximum residue levels (MRLs)
MRLs are set at European Level and the review is performed by EFSA. The EU MRLs and calculated
MRLs for the crops considered in this dossier are summarised in Table 8.7.2-1. An MRL exceedance is
not expected for the intended indoor uses in other leafy vegetables excluding witloof chicory (watercress,
lamb’s lettuce, rocket, sea lavender), endive, and baby leaf crops. In contrast, the MRL for herbs and
edible flowers/aromatic herbs is expected to be exceeded..No trials are available for evaluation of the
intended use in the whole subgroup of leafy brassica.
In agreement with the applicant, the intended use in leafy brassica was restricted to Chinese cabbage only
Table 8.7.2-1: EU MRLs set for the uses of spirotetramat
Crop STMR
(mg/kg)
HR
(mg/kg)
OECD
calculator
MRL
(mg/kg)
EU MRL
(mg/kg)
MRL com-
pliance
Other leafy vegetables
excluding witloof
chicory (watercress,
lamb’s lettuce, rocket,
sea lavender)
1.54 3.44 6.0 7.0 Y
Endive 1.54 3.44 6.0 7.0 Y
Baby leaf crops 1.54 3.44 6.0 7.0 Y
Leafy brassica 1.1 1.9 4.0 7.0 Y
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 20 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Crop STMR
(mg/kg)
HR
(mg/kg)
OECD
calculator
MRL
(mg/kg)
EU MRL
(mg/kg)
MRL com-
pliance
Chinese cabbage1
Whole subgroup of
herbs and edible
flowers/ aromatic herbs
1.54 3.44 6.0 4.0 Y2
1 In agreement with the applicant, the intended use in leafy brassica was amended to Chinese cabbage in
the course of the evaluation. 2 Based upon expert judgement, it is not expected that MRLs will be exceeded. It is referred to Section
IIIA 8.3.5 for more details.
IIIA 8.8 Proposed Pre-Harvest Intervals, Re-Entry or Withholding Periods
IIIA 8.8.1 Pre-harvest interval (in days) for each relevant crop
The PHI is specified in the GAP enclosed to this application.
IIIA 8.8.2 Re-entry period (in days) for livestock, to areas to be grazed
No re-entry or withholding periods are proposed.
IIIA 8.8.3 Re-entry period for man to crops, buildings or spaces treated
Not applicable.
IIIA 8.8.4 Withholding period (in days) for animal feedingstuffs
Not applicable.
IIIA 8.8.5 Waiting period before sowing or planting crop to be protected
Not applicable.
IIIA 8.8.6 Waiting period between application and handling treated products
Not applicable, as residues do not present a risk.
IIIA 8.8.7 Waiting period (in days) before sowing or planting succeeding crops
Not applicable, as no residues are expected in succeeding crops.
IIIA 8.9 Other/Special Studies
Other special studies are not needed.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 21 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.10 Estimation of Exposure Through Diet and Other Means
The ADI and ARfD values for spirotetramat are summarised in the table below.
Active substance End-Point Value
(mg/kg bw/day)
Study Safety factor Reference
Spirotetramat Acceptable
Daily Intake
(ADI)
0.05 Based on 1-year dog
study
100 EFSA, 2013
Acute
Reference
Dose (ARfD)
1 Based on acute
neurotoxicity rat
study
100 EFSA, 2013
In order to evaluate the potential chronic and acute exposure to spirotetramat residues through the diet,
the intakes were estimated using the EFSA PRIMo (revision 2). This exposure assessment model contains
the relevant European food consumption data for different sub-groups of the EU population. For the
calculation of chronic and acute exposure, use is made of the input values for commodities from the latest
EFSA opinion (EFSA Journal 2017;15(1):4684). These input values cover the intended uses of Batavia
except for herbs and edible flowers. Since this use is currently not recommended for authorisation due to
an MRL exceedance, it is not considered necessary to perform a new consumer risk assessment. Before
the use in herbs and edible flowers may be authorised, an MRL application needs to be submitted in
which the consumer risk assessment will be conducted based on the available data.
Long-term or acute consumer intake concerns were not identified by EFSA for any of the European diets
incorporated in the EFSA PRIMo. The highest chronic intake accounted for 37% of the ADI (WHO
cluster B) and the highest acute exposure for 48% of the ARfD for escarole (German toddler) which is
also a crop under consideration in this dossier.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 22 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
IIIA 8.11 Summary and Evaluation of Residue Behaviour
The plant protection product Batavia (15615 N) is authorised in the Netherlands for indoor use on various
edible and non-edible commodities. With the current application, the applicant seeks for registration of
minor indoor uses in: other leafy vegetables excluding witloof chicory (watercress, lamb’s lettuce, rocket,
sea lavender), endive, vegetables sprouts, baby leaf crops, leafy brassica, aromatic herbs, and plant
breeding crops and basic seed production. Since the intended indoor use in plant breeding crops and basic
seed production is not relevant for the section of residues and consumer safety, this intended use was not
discussed in this document.
The majority of information and data were already evaluated in the main authorisation. The metabolism
of spirotetramat in plants, animals, rotational crops, and processed commodities is covered by the main
authorisation. Likewise, storage stability was sufficiently demonstrated before.
Other leafy vegetables excluding witloof chicory (watercresses, lamb’s lettuce, rocket, sea
lavender); endives; baby leaf crops; aromatic herbs
cGAP-NL: 2 x 75 g a.s./ha, interval 14 d, PHI 7 d
Three studies investigating the magnitude of spirotetramat residues in lettuce are available that were
already evaluated in the DAR by Austria and by EFSA during the peer review of spirotetramat to support
the representative indoor use in lettuce according to the GAP 2 x 72 g/ha, interval 14 d, PHI 7 d (Austria,
2013; EFSA, 2013). The studies were considered acceptable and were therefore not summarised in detail
anymore within this application. Residue levels were selected according to the residue definitions that are
currently in force. The slight difference in the application rate between the peer review and the current
application (72 g/ha cf. 75 g/ha) is considered to have a negligible impact on the residue levels.
According to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on open leaf varieties of lettuce can be
extrapolated to watercresses, lamb’s lettuce, rocket, sea lavender, endives, baby leaf crops, and the whole
subgroup of herbs and edible flowers. It is noted that: (i) sea lavender falls under purslanes in Annex I of
Reg. (EC) No 396/2005 and therefore, the MRL of purslanes applied to sea lavender; and (ii) due to a
discrepancy between Annex I of Reg. (EC) No 396/2005 and the Dutch list of uses, the subgroup of herbs
and edible flowers as listed in Annex I only includes the aromatic herbs as listed in the Dutch list of uses.
Therefore, an application was made for aromatic herbs according to the Dutch list of uses.
Watercresses, lamb’s lettuce, rocket, sea lavender, endives, baby leaf crops, and the whole subgroup of
herbs and edible flowers are all minor crops in NEU; therefore, 4 trials are considered sufficient for
evaluation. From the available trials, 10 trials were conducted on open leaf varieties and are considered
for evaluation. Based upon these trials, an MRL of 6.00 mg/kg is calculated. Existing MRLs of
spirotetramat as established by Reg. (EU) No 2017/1016 in watercresses, lamb’s lettuce, rocket, and
purslanes/sea lavanders, endives, and baby leaf crops are at 7.00 mg/kg; an MRL exceendance is not
expected. In contrast, the existing MRL of spirotetramat in herbs and edible flowers is at 4.0 mg/kg; i.e.
an MRL exceedance cannot be excluded. At the time point of MRL setting (EFSA, 2011), the same data
set was available as the one presented in this dossier. In the Reasoned Opinion, however, a mistake was
apparently made since the highest residue from the greenhouse trials in open leaf varieties (3.442 mg/kg)
was not considered in the Reasoned Opinion. There are no obvious reasons why this value should be
discarded from the data set. Therefore, the value is considered within this application. As a consequence,
the existing MRL is expected to be exceeded. However, considering that 7 out of the 10 available trials
were conducted with three applications instead of the intended two, residue levels are rather
overestimated. This is highlighted by the fact that the three available trials conducted with two
applications resulted in lower residue levels (0.74-1.057 mg/kg cf. 1.296-3.442 mg/kg for two and three
applications, respectively). Based upon expert judgement, it is not expected that the existing MRL will be
exceeded if aromatic herbs are treated according to the intended GAP.
Leafy brassica
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 23 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
cGAP-NL: 2 x 75 g a.s./ha, interval 14 d, PHI 3 d
To support the indoor use in leafy brassica, two new studies with, in total, four trials in paksoi were
submitted. Paksoi falls under Chinese cabbages/pe-tsai in Annex I of Reg. (EC) No 396/2005. According
to SANCO/7525/VI/95 Rev. 9 (March 2011), trials on Chinese cabbages cannot be used to support the
intended use in the whole subgroup of leafy brassica. Therefore, no trials are available for evaluation. The
intended use in leafy brassica is not recommended for authorisation.
In agreement with the applicant, the intended use in leafy brassica was restricted to Chinese cabbage only.
Based upon the available trials in paksoi, an MRL of 4.00 mg/kg is calculated. The existing MRL of
spirotetramat as established by Reg. (EU) No 2017/1016 in Chinese cabbage is at 7.00 mg/kg; an MRL
exceendance is not expected.
Of the crops under consideration only kale, which falls under the leafy brassica, may be fed to livestock.
Since the intended use in leafy brassica was restricted to Chinese cabbage only during the course of the
evaluation, none of the intended uses are fed to livestock and therefore the aspect of residues in livestock
does not need to be addressed.
Residues in succeeding crops are covered by the main authorisation.
The dietary risk estimated for a short-term or a long-term consumption of residues of spirotetramat was
estimated using the EFSA PRIMo model rev. 2. No acute or chronic risk to the consumer was identified.
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 24 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Appendix 1: List of data submitted in support of the extension of use
Annex
point
Year Title
Source (where different
from company)
Company name,
Report No., Date,
GLP/GEP status
(where relevant)
published or not
Study
relied
on
Owner Application
number of
first
submission
Date of
first
submission
(Document)
KCP
8.3/01
2006 Determination of the
residues of BYI 08330
in/on lettuce after
spraying of BYI 08330
(150 OD) in the
greenhouse in Greece,
France, Netherlands,
Portugal, Germany and
Spain
Bayer
Report No.: RA-2170/05
Edition Number: M-
272108-01-1
Date: 2006-05-31
GLP/GEP: Yes,
unpublished
Yes Bayer 20071148 TG
(Movento)
2009-10-30
KCP
8.3/02
2005 Determination of the
residues of BYI 08330
in/on lettuce after
spraying of BYI 08330
(100 OD) in the
greenhouse in Germany,
Southern France, Italy
and Spain
Bayer
Report No.: RA-2054/04
Edition Number: M-
262616-01-1
Date: 2005-12-15
GLP/GEP: Yes,
unpublished
Yes Bayer 20071148 TG
(Movento)
2009-10-30
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 25 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Annex
point
Year Title
Source (where different
from company)
Company name,
Report No., Date,
GLP/GEP status
(where relevant)
published or not
Study
relied
on
Owner Application
number of
first
submission
Date of
first
submission
(Document)
KCP
8.3/03
2005 Determination of the
residues of BYI 08330
in/on lettuce after
spraying of BYI 08330
(240 SC) in the
greenhosue in Germany,
Italy and Spain
Bayer
Report No.: RA-2113/04
Edition Number: M-
261625-01-1
Date: 2005-11-15
GLP/GEP: Yes,
unpublished
Yes Bayer 20071148 TG
(Movento)
2009-10-30
KCP
8.3/04
2012 Determination of the
magnitude of residues of
spirotetramat and its
metabolites in protected
Paksoi after 2 applications
with Movento in the
Netherlands, 2012
Final Report R12-35-NL-
02
de Breedelaar BV
Date: 28-02-2013
GLP/GEP: Yes,
unpublished
Yes Fonds
Kleine
Toepassi
ngen
Batavia
20181727
NLKUG
-
KCP
8.3/05
2012 Determination of the
decline of the residues of
spirotetramat and its
metabolites in protected
Paksoi after 2 applications
with Movento in the
Netherlands, 2012
Final Report R12-35-NL-
01
de Breedelaar BV
Date: 24-09-2012
GLP/GEP: Yes,
unpublished
Yes Fonds
Kleine
Toepassi
ngen
Batavia
20181727
NLKUG
-
Part B – Section 4
National Assessment
Batavia
Registration Report
Page 26 of 26
Applicant: Bayer CropScience Evaluator: Ctgb-NL
Date: January 2019
Appendix 2: Critical Uses – justification and GAP tables
The critical uses for the risk envelope are indicated in the relevant parts of the risk assessment in this
section.
Appendix 3: Pesticide Residue Intake Model (PRIMO)
No new consumer risk assessment was performed since this is covered by the latest EFSA reasoned
opinion (EFSA, 2017).